Strategies in the design of nanoparticles for therapeutic applications

被引:2882
作者
Petros, Robby A. [1 ]
DeSimone, Joseph M. [2 ,3 ,4 ,5 ]
机构
[1] Univ N Texas, Dept Chem, Denton, TX 76203 USA
[2] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[5] N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA
基金
美国国家科学基金会;
关键词
DRUG-DELIVERY SYSTEMS; B-CELL LYMPHOMA; PHASE-I; TARGETED DELIVERY; INTRACELLULAR TRAFFICKING; CHEMOTHERAPEUTIC-AGENTS; COMPLEMENT ACTIVATION; ALBUMIN MICROSPHERES; CANCER-CHEMOTHERAPY; CONTROLLED-RELEASE;
D O I
10.1038/nrd2591
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Engineered nanoparticles have the potential to revolutionize the diagnosis and treatment of many diseases; for example, by allowing the targeted delivery of a drug to particular subsets of cells. However, so far, such nanoparticles have not proved capable of surmounting all of the biological barriers required to achieve this goal. Nevertheless, advances in nanoparticle engineering, as well as advances in understanding the importance of nanoparticle characteristics such as size, shape and surface properties for biological interactions, are creating new opportunities for the development of nanoparticles for therapeutic applications. This Review focuses on recent progress important for the rational design of such nanoparticles and discusses the challenges to realizing the potential of nanoparticles.
引用
收藏
页码:615 / 627
页数:13
相关论文
共 173 条
[31]   Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel [J].
Danhier, Fabienne ;
Vroman, Benoit ;
Lecouturier, Nathalie ;
Crokart, Nathalie ;
Pourcelle, Vincent ;
Freichels, Helene ;
Jerome, Christine ;
Marchand-Brynaert, Jacqueline ;
Feron, Olivier ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2009, 140 (02) :166-173
[32]   The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer [J].
Daniels, Tracy R. ;
Delgado, Tracie ;
Rodriguez, Jose A. ;
Helguera, Gustavo ;
Penichet, Manuel L. .
CLINICAL IMMUNOLOGY, 2006, 121 (02) :144-158
[33]   The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells [J].
Daniels, Tracy R. ;
Delgado, Tracie ;
Helguera, Gustavo ;
Penichet, Manuel L. .
CLINICAL IMMUNOLOGY, 2006, 121 (02) :159-176
[34]   Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP 1049C) in patients with advanced cancer [J].
Danson, S ;
Ferry, D ;
Alakhov, V ;
Margison, J ;
Kerr, D ;
Jowle, D ;
Brampton, M ;
Halbert, G ;
Ranson, M .
BRITISH JOURNAL OF CANCER, 2004, 90 (11) :2085-2091
[35]   Nanoparticle therapeutics: an emerging treatment modality for cancer [J].
Davis, Mark E. ;
Chen, Zhuo ;
Shin, Dong M. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) :771-782
[36]   Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles [J].
Davis, Mark E. ;
Zuckerman, Jonathan E. ;
Choi, Chung Hang J. ;
Seligson, David ;
Tolcher, Anthony ;
Alabi, Christopher A. ;
Yen, Yun ;
Heidel, Jeremy D. ;
Ribas, Antoni .
NATURE, 2010, 464 (7291) :1067-U140
[37]   The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic [J].
Davis, Mark E. .
MOLECULAR PHARMACEUTICS, 2009, 6 (03) :659-668
[38]   Size and shape effects in the biodistribution of intravascularly injected particles [J].
Decuzzi, P. ;
Godin, B. ;
Tanaka, T. ;
Lee, S. -Y. ;
Chiappini, C. ;
Liu, X. ;
Ferrari, M. .
JOURNAL OF CONTROLLED RELEASE, 2010, 141 (03) :320-327
[39]   Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? [J].
Decuzzi, Paolo ;
Pasqualini, Renata ;
Arap, Wadih ;
Ferrari, Mauro .
PHARMACEUTICAL RESEARCH, 2009, 26 (01) :235-243
[40]   Integrins in cancer: biological implications and therapeutic opportunities [J].
Desgrosellier, Jay S. ;
Cheresh, David A. .
NATURE REVIEWS CANCER, 2010, 10 (01) :9-22